Härk, H.H.; Porosk, L.; de Mello, L.R.; Arukuusk, P.; da Silva, E.R.; Kurrikoff, K.
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications. Pharmaceutics 2023, 15, 883.
https://doi.org/10.3390/pharmaceutics15030883
AMA Style
Härk HH, Porosk L, de Mello LR, Arukuusk P, da Silva ER, Kurrikoff K.
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications. Pharmaceutics. 2023; 15(3):883.
https://doi.org/10.3390/pharmaceutics15030883
Chicago/Turabian Style
Härk, Heleri H., Ly Porosk, Lucas R. de Mello, Piret Arukuusk, Emerson R. da Silva, and Kaido Kurrikoff.
2023. "Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications" Pharmaceutics 15, no. 3: 883.
https://doi.org/10.3390/pharmaceutics15030883
APA Style
Härk, H. H., Porosk, L., de Mello, L. R., Arukuusk, P., da Silva, E. R., & Kurrikoff, K.
(2023). Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications. Pharmaceutics, 15(3), 883.
https://doi.org/10.3390/pharmaceutics15030883